New Key Statistics Module, Z-Score and F-Score
OTCPK:TRGNF Key Ratios
| Market Cap $ M | 132.77 |
| Enterprise Value $ M | 125.11 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 17.87 |
| Price/Book | -- |
| Price/Sales | 495.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.24 |
| Beneish M-Score | -1.67 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.21 |
| EV-to-EBITDA | -5.55 |
| PEG | -- |
| Shares Outstanding M | 132.29 |
| Net Margin (%) | -7,586.42 |
| Operating Margin % | -10,344.70 |
| Pre-tax Margin (%) | -7,586.42 |
| Quick Ratio | 1.57 |
| Current Ratio | 1.57 |
| ROA % (ttm) | -47.23 |
| ROE % (ttm) | -185.99 |
| ROIC % (ttm) | -99.50 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.99 |
TRGNF Number of Guru Trades
TRGNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TRGNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TRGNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Transgene SA Insider Transactions
No Available Data
News about OTCPK:TRGNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers